Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of human papillomavirus in anal squamous cell carcinoma.
Ravenda PS, Magni E, Botteri E, Manzotti M, Barberis M, Vacirca D, Trovato CM, Dell'Acqua V, Leonardi MC, Sideri M, Fazio N, Zampino MG. Ravenda PS, et al. Cancer Chemother Pharmacol. 2014 Nov;74(5):1033-8. doi: 10.1007/s00280-014-2582-x. Epub 2014 Sep 11. Cancer Chemother Pharmacol. 2014. PMID: 25209946
Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Dell'Acqua V, Surgo A, Arculeo S, Zerella MA, Bagnardi V, Frassoni S, Zampino MG, Ravenda PS, Rotundo MS, Kraja F, Kobiela J, Spychalski P, Fodor C, Gerardi MA, Cattani F, Bazani A, Petz W, Glynne-Jones R, Orecchia R, Leonardi MC, Jereczek-Fossa BA. Dell'Acqua V, et al. Int J Colorectal Dis. 2020 Apr;35(4):685-694. doi: 10.1007/s00384-020-03517-x. Epub 2020 Feb 8. Int J Colorectal Dis. 2020. PMID: 32036405
Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.
Dell'Acqua V, Kobiela J, Kraja F, Leonardi MC, Surgo A, Zerella MA, Arculeo S, Fodor C, Ricotti R, Zampino MG, Ravenda S, Spinoglio G, Biffi R, Bazani A, Luraschi R, Vigorito S, Spychalski P, Orecchia R, Glynne-Jones R, Jereczek-Fossa BA. Dell'Acqua V, et al. Med Oncol. 2018 Mar 28;35(5):59. doi: 10.1007/s12032-018-1118-3. Med Oncol. 2018. PMID: 29594584
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).
Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P. Casadei-Gardini A, et al. Cancer Manag Res. 2019 Apr 26;11:3631-3642. doi: 10.2147/CMAR.S197349. eCollection 2019. Cancer Manag Res. 2019. PMID: 31118786 Free PMC article.
Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center.
Rotundo MS, Zampino MG, Ravenda PS, Bagnardi V, Peveri G, Dell'Acqua V, Surgo A, Trovato C, Bottiglieri L, Bertani E, Petz WL, Fumagalli Romario U, Fazio N. Rotundo MS, et al. Among authors: dell acqua v. Ther Adv Med Oncol. 2020 Jul 15;12:1758835920940945. doi: 10.1177/1758835920940945. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32728394 Free PMC article.
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series.
Leonardi MC, Corrao G, Frassoni S, Vingiani A, Dicuonzo S, Lazzeroni M, Fodor C, Morra A, Gerardi MA, Rojas DP, Dell'Acqua V, Marvaso G, Bassi FD, Galimberti VE, Veronesi P, Miglietta E, Cattani F, Zurrida S, Bagnardi V, Viale G, Orecchia R, Jereczek-Fossa BA. Leonardi MC, et al. Radiother Oncol. 2019 Apr;133:68-76. doi: 10.1016/j.radonc.2018.12.030. Epub 2019 Jan 17. Radiother Oncol. 2019. PMID: 30935584
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place.
Dicuonzo S, Leonardi MC, Radice D, Morra A, Gerardi MA, Rojas DP, Surgo A, Dell'Acqua V, Luraschi R, Cattani F, Rietjens M, De Lorenzi F, Veronesi P, Galimberti V, Marvaso G, Fodor C, Orecchia R, Jereczek-Fossa BA. Dicuonzo S, et al. Among authors: dell acqua v. Plast Reconstr Surg. 2020 Feb;145(2):317-327. doi: 10.1097/PRS.0000000000006441. Plast Reconstr Surg. 2020. PMID: 31985612
37 results